SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,830.00    135.00 (2.02%)
Bid:
6,825.00
Ask:
6,835.00
Spread: 10.00 (0.147%)
Market Cap: £5.04b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

15 May 2012 07:00

RNS Number : 3206D
Spirax-Sarco Engineering PLC
15 May 2012
 



 

Spirax-Sarco Engineering plc

 

Charlton House

Cheltenham

Glos. GL53 8ER

 

 

News Release

 

 

 

Telephone: 01242 521361

Fax: 01242 581470

www.SpiraxSarcoEngineering.com

 

Tuesday 15th May 2012

INTERIM MANAGEMENT STATEMENT

 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement in respect of the period from 1st January 2012, ahead of its Annual General Meeting today at 2.00pm.

 

Trading

Organic sales growth was 6% for the four months ended 30th April 2012. However, total sales increased 3% due to unfavourable exchange movements, particularly in recent weeks, that reduced sales on translation by 2%, and due to the impact of two small business disposals in mid-2011. At constant currency, operating profit was modestly ahead of the comparable period in 2011. This reflected the contribution from the higher sales, largely offset by higher material costs (the effects of which are expected to reduce in the second half of the year), lower volumes in our main European factories and the impact of the economic downturn in Latin America.

 

Overall, trading conditions have been consistent with the commentary in our last update in early March. Our markets in Asia continue to broadly show good strength and North America is benefiting from increased project activity and continued investment in the oil sands developments of Western Canada. Trading conditions remain difficult, as expected, in our core European markets. The market environment in Latin America reflects the slower economic growth in the region and decline in industrial production in Brazil.

 

We remain focused on our strategic priorities to drive sales growth, especially in emerging markets, to generate benefits from our increased investment in R&D over the last few years and to improve operational excellence. We believe that economic conditions in Europe will remain sluggish and therefore we are intensifying our focus on cost reduction and operating efficiency.

 

Financial position

Our balance sheet remains strong and the Group had a net cash balance of £29 million at 30th April 2012 compared with £12 million at 31st December 2011. There has been no material change in the financial position of the Group during the period and the principal risks and uncertainties remain those set out on pages 26 and 27 of the 2011 Annual Report.

 

Outlook

Our geographically diverse business generally reflects changes in economic growth and rates of industrial production. Although economic growth rates have slowed from last year, trading conditions in the first four months of 2012 have been broadly in line with our expectations. We note that sterling has recently strengthened and, if current exchange rates prevail, this would reduce sales on translation by over 3% for the full year. However, given no additional market weakness, our fundamental strengths and resilient business model give the Board confidence that the Group will make further progress in 2012.

 

Spirax Sarco will publish its interim results on 22nd August 2012.

 

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535234

 

 

 

 

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and peristaltic pumping. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,700 people, of whom around 1,300 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLGDUXSBBGDS
Date   Source Headline
1st Mar 20227:30 amRNSChange of Director Details
31st Jan 20227:00 amRNSCompletion of the acquisition of Cotopaxi
24th Jan 20227:00 amRNSAcquisition to accelerate digital strategy
17th Nov 20217:00 amRNSTrading Update
15th Nov 20211:54 pmRNSDirector/PDMR Shareholding
11th Aug 20214:46 pmRNSCorrection to Dividend Record Date in News Release
11th Aug 20217:00 amRNS2021 Half Year Results
3rd Aug 20217:00 amRNSBoard Changes
22nd Jun 20217:00 amRNSDirector/PDMR Shareholding
17th Jun 20217:00 amRNSNew Sustainability Targets Launched
4th Jun 20218:12 amRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSNews Release - Investor Seminar
12th May 20214:53 pmRNSResult of AGM
12th May 20217:00 amRNSAGM TRADING UPDATE
10th May 20219:16 amRNSDirector/PDMR Shareholding
12th Apr 202111:44 amRNSDirector/PDMR Shareholding
26th Mar 20218:12 amRNSDirector/PDMR Shareholding
10th Mar 20217:00 amRNS2020 Preliminary Results
9th Mar 20218:30 amRNSBoard Appointment
7th Jan 20214:05 pmRNSDirector/PDMR Shareholding
14th Dec 202010:00 amRNSDirector/PDMR Shareholding
18th Nov 20207:00 amRNSTrading Update
9th Nov 20209:00 amRNSBoard Appointments
21st Oct 20209:21 amRNSChange of Director Details
12th Oct 20205:08 pmRNSDirector/PDMR Shareholding
12th Oct 202010:00 amRNSDirectorate Change
14th Sep 20208:00 amRNSChief Financial Officer
18th Aug 20204:19 pmRNSDirector/PDMR Shareholding
12th Aug 20207:00 amRNS2020 Half Year Results
6th Aug 20208:00 amRNSAdditional Listing
28th Jul 202012:24 pmRNSSection 430(2b) Companies Act - Nimesh Patel
23rd Jul 20207:30 amRNSChange of Director Details
22nd Jun 20203:39 pmRNSChange of Director Details
22nd Jun 20202:45 pmRNSDirector/PDMR Shareholding
20th May 20209:00 amRNSChange of Director Details
13th May 20204:32 pmRNSResult of AGM
13th May 20207:00 amRNSAGM Statement - Trading Update
28th Apr 202011:30 amRNSDisclosure of Rights attached to Equity Shares
24th Apr 20208:59 amRNSAGM Alternative Arrangements
8th Apr 202010:33 amRNSSection 430(2B) Companies Act 2006 Statement
3rd Apr 202011:14 amRNSDirector/PDMR Shareholding
2nd Apr 20208:00 amRNSSpirax Sarco appoints next Chief Financial Officer
30th Mar 20208:30 amRNSChange of Director Details
13th Mar 20209:48 amRNSDirector/PDMR Shareholding
12th Mar 202012:00 pmRNSDirector/PDMR Shareholding
11th Mar 20207:05 amRNSBoard Change
11th Mar 20207:00 amRNS2019 Preliminary Results
7th Feb 20205:35 pmRNSDirector Declaration
13th Nov 20197:00 amRNSTrading Update
10th Sep 20193:30 pmRNSChange of Director Details

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.